All In MedTech

Device Trial Radar · NCT07902115

Vocxi Breath Analyzer Study in Pediatric Respiratory Infection

Vocxi Breath Analyzer Study

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Oct 27, 2026

Primary completion

Mar 1, 2027

Study completion Mar 1, 2027

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 28, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 7 years, up to 17 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This pilot study will evaluate whether the MBP® Breath Analyzer can collect measurable volatile organic compound signals from pediatric participants with acute respiratory illness and from healthy pediatric controls. Children aged 7 to 17 years presenting to the Masonic Children's Hospital Pediatric Emergency Department will be enrolled. One group will include participants with signs or symptoms of acute respiratory illness, and the control group will include participants presenting for minor injuries without respiratory symptoms. Participants will breathe normally into the MBP® Breath Analyzer for approximately 1 minute. VOC signal data will be analyzed to assess device performance and to explore whether breath VOC patterns differ between pediatric participants with respiratory infection and healthy controls.

Conditions

  • Acute Respiratory Illness
  • Viral Respiratory Infection

Interventions

  • MBP® Breath AnalyzerDevice

    The MBP® Breath Analyzer is a handheld breath sensor connected to a secure dedicated study mobile phone with the Vocxi app. A mask is connected to the device, and the participant breathes normally into the mask for approximately 1 minute. The system collects volatile organic compound signal data from exhaled breath for research analysis. The device will not be used to diagnose, treat, or guide clinical care.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful Breath Sample Collection Using the MBP® Breath AnalyzerTime frame: During the study visit, approximately 45 minutes
  2. Measurable VOC Signals From Pediatric Breath SamplesTime frame: During the study visit, approximately 45 minutes

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Minnesota Masonic Children's Hospital Pediatric Emergency Department

    Minneapolis, Minnesota · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.